🇺🇸 FDA
Patent

US 6339072

Compositions and methods for preventing restenosis following revascularization procedures

expired A61KA61K31/00A61K31/4545

Quick answer

US patent 6339072 (Compositions and methods for preventing restenosis following revascularization procedures) held by Discovery Therapeutics, Inc. expires Mon Jan 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Discovery Therapeutics, Inc.
Grant date
Tue Jan 15 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/00, A61K31/4545, A61K31/52, A61K31/522